1. Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. (10th August 2014) Authors: Zhang, X.; Brooks, B.; Molyneaux, L.; Landy, E.; Banatwalla, R.; Wu, T.; Wong, J.; Su, B.; Yue, D. K. Other Names: Kengne Andre P. Academic Editor. Journal: International journal of endocrinology Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗